Publicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (3)

2014

  1. Angiogenesis inhibitor therapies for advanced renal cell carcinoma: Toxicity and treatment patterns in clinical practice from a global medical chart review

    International Journal of Oncology, Vol. 44, Núm. 1, pp. 5-16

  2. Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: A medical chart review across ten centers in five European countries

    Cancer Medicine, Vol. 3, Núm. 6, pp. 1517-1526

2013

  1. Safety and treatment patterns of angiogenesis inhibitors in patients with advanced renal cell carcinoma in Spain

    Expert Opinion on Drug Safety, Vol. 12, Núm. 4, pp. 455-463